RANDLE MISKELLY: Open Payments
NPI 1013948066 · HENDERSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,409 in 87 payments from 14 companies in 2025. Trend: 2023 $1,299 · 2024 $1,585 · 2025 $1,409
Food & beverage: $1,409
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $351 |
| Novo Nordisk Inc | 13 | $229 |
| PFIZER INC. | 15 | $220 |
| Amgen Inc. | 11 | $155 |
| Lilly USA, LLC | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
Products named: VRAYLAR, OTEZLA, NURTEC ODT, Ozempic, Wegovy, REXULTI, CAPLYTA, Kerendia.
Industry payments across TN — which companies pay providers there.
